Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Laobaixing Drugstore Chain Secures $80 Million From EQT Partners Asia

This article was originally published in PharmAsia News

Executive Summary

Hunan Laobaixing Chain Drugstore has successfully secured capital infusion of more than $80 million from EQT Partners Asia, a subsidiary of Sweden-based Investor AB. This represents the largest overseas fund injection for China's drug retail industry in recent years. The deal effectively makes Laobaixing a Sino-foreign equity joint venture and reflects international investment confidence in China's drug retail market. After receiving the capital, Laobaixing will further establish its chain and expand in the domestic market as well as adopt an advanced international management system. The company is expected to go public between 2010 and 2011. (Click here for more - Chinese Language)
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067006

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel